Nalaganje...
Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition
BACKGROUND AND PURPOSE: Mitochondrial dysfunction, triggered by mitochondria permeability transition (MPT), has been centrally implicated in the pathogenesis of podocytopathy and involves a multitude of cell signalling mechanisms, among which, glycogen synthase kinase (GSK) 3β has emerged as the int...
Shranjeno v:
| izdano v: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4301697/ https://ncbi.nlm.nih.gov/pubmed/25262943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12952 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|